搜尋





搜尋





市場行情
/
股票
/
pasg
/

Passage Bio Inc

PASG

添加自選

4.470USD

-0.020-0.45%

收盤 07-31 16:00（美東）報價延遲15分鐘

14.23M總市值

虧損本益比TTM

Passage Bio Inc

4.470

-0.020-0.45%

概覽

財務

分析

公司

財務摘要利潤表資產負債表現金流量表

PASG 利潤表

您可以在這裡找到Passage Bio Inc的年度或季度收入報告，以深入了解Passage Bio Inc的營運、管理效率和表現。

單季報

單季報+年報

單季報

年報

YOY

隱藏空白列

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

FY2020Q2

FY2020Q1

FY2019Q4

FY2019Q3

FY2019Q2

FY2019Q1

營業費用

-35.75%8.88M

-27.54%10.34M

-45.59%8.65M

-39.00%10.33M

-23.42%13.82M

-22.64%14.27M

-31.68%15.91M

-33.28%16.94M

-49.70%18.05M

-34.69%18.45M

-15.42%23.28M

-36.23%25.39M

-16.18%35.88M

-44.79%28.24M

-41.56%27.53M

-17.97%39.81M

9.96%42.81M

30.99%51.16M

64.52%47.10M

77.75%48.53M

117.36%38.93M

187.35%39.06M

145.90%28.63M

251.54%27.30M

327.80%17.91M

--13.59M

--11.64M

--7.77M

--4.19M

研發費用

-47.10%4.09M

-43.31%5.42M

-50.24%4.31M

-44.26%5.81M

-32.93%7.74M

-21.40%9.56M

-42.67%8.66M

-39.79%10.43M

-31.49%11.54M

-31.13%12.16M

-10.46%15.10M

-35.41%17.32M

-39.25%16.84M

-48.02%17.66M

-47.51%16.86M

-19.00%26.82M

4.70%27.71M

17.41%33.97M

54.16%32.12M

66.38%33.11M

101.80%26.47M

190.13%28.93M

99.70%20.84M

192.72%19.90M

332.48%13.12M

--9.97M

--10.43M

--6.80M

--3.03M

折舊攤銷及損耗

-35.82%129.00K

-75.38%177.00K

-75.00%200.00K

-75.06%201.00K

-10.90%719.00K

-20.00%800.00K

-19.40%806.00K

-14.69%807.00K

7.64%1.00M

8.58%1.00M

13.25%1.00M

41.41%946.00K

101.96%929.00K

353.69%921.00K

318.48%883.00K

140.65%669.00K

67.27%460.00K

2.53%203.00K

330.61%211.00K

517.78%278.00K

570.73%275.00K

450.00%198.00K

308.33%49.00K

--45.00K

--41.00K

--36.00K

--12.00K

營業利潤

35.75%-8.88M

27.54%-10.34M

45.59%-8.65M

39.00%-10.33M

23.42%-13.82M

22.64%-14.27M

31.68%-15.91M

33.28%-16.94M

49.70%-18.05M

34.69%-18.45M

15.42%-23.28M

36.23%-25.39M

16.18%-35.88M

44.79%-28.24M

41.56%-27.53M

17.97%-39.81M

-9.96%-42.81M

-30.99%-51.16M

-64.52%-47.10M

-77.75%-48.53M

-117.36%-38.93M

-187.35%-39.06M

-145.90%-28.63M

-251.54%-27.30M

-327.80%-17.91M

---13.59M

---11.64M

---7.77M

---4.19M

淨非營業利息收入（費用）

利息收入

-57.14%300.00K

-37.50%500.00K

-54.55%500.00K

-50.00%600.00K

-46.15%700.00K

-63.64%800.00K

37.50%1.10M

-20.00%1.20M

18.18%1.30M

87.55%2.20M

-3.03%800.00K

455.56%1.50M

109900.00%1.10M

19450.00%1.17M

343.55%825.00K

172.73%270.00K

-98.08%1.00K

-94.64%6.00K

87.88%186.00K

-25.00%99.00K

-84.10%52.00K

-74.60%112.00K

-61.18%99.00K

--132.00K

--327.00K

--441.00K

--255.00K

--0.00

特殊收入（費用）

124.00%633.00K

---3.51M

100.00%0.00

----

---2.64M

--0.00

11.04%-4.79M

---438.00K

----

--0.00

---5.39M

----

--0.00

100.00%0.00

--0.00

---5.66M

---3.48M

其他非經營性收入（費用）

9.60%388.00K

-51.01%365.00K

54.96%406.00K

86.63%349.00K

807.69%354.00K

245.51%745.00K

-65.62%262.00K

484.38%187.00K

-91.24%39.00K

---512.00K

--762.00K

--32.00K

--445.00K

----

稅前利潤

50.93%-7.56M

-2.03%-12.98M

59.93%-7.75M

41.31%-9.38M

7.82%-15.40M

24.07%-12.72M

28.66%-19.34M

32.97%-15.99M

51.33%-16.71M

38.10%-16.76M

-1.53%-27.11M

39.67%-23.86M

19.79%-34.34M

47.08%-27.07M

43.09%-26.70M

18.36%-39.54M

-10.10%-42.81M

-31.35%-51.15M

-64.44%-46.91M

-78.25%-48.44M

-121.11%-38.88M

-196.13%-38.94M

-150.54%-28.53M

-102.38%-27.17M

-129.30%-17.59M

---13.15M

---11.39M

---13.43M

---7.67M

所得稅

----

--0.00

----

除稅後利潤

50.93%-7.56M

-2.03%-12.98M

59.93%-7.75M

41.31%-9.38M

7.82%-15.40M

24.07%-12.72M

28.66%-19.34M

32.97%-15.99M

51.33%-16.71M

38.10%-16.76M

-1.53%-27.11M

39.67%-23.86M

19.79%-34.34M

47.08%-27.07M

43.09%-26.70M

18.36%-39.54M

-10.10%-42.81M

-31.35%-51.15M

-64.44%-46.91M

-78.25%-48.44M

-121.11%-38.88M

-196.13%-38.94M

-150.54%-28.53M

-102.38%-27.17M

-129.30%-17.59M

---13.15M

---11.39M

---13.43M

---7.67M

持續經營利潤

50.93%-7.56M

-2.03%-12.98M

59.93%-7.75M

41.31%-9.38M

7.82%-15.40M

24.07%-12.72M

28.66%-19.34M

32.97%-15.99M

51.33%-16.71M

38.10%-16.76M

-1.53%-27.11M

39.67%-23.86M

19.79%-34.34M

47.08%-27.07M

43.09%-26.70M

18.36%-39.54M

-10.10%-42.81M

-31.35%-51.15M

-64.44%-46.91M

-78.25%-48.44M

-121.11%-38.88M

-196.13%-38.94M

-150.54%-28.53M

-102.38%-27.17M

-129.30%-17.59M

---13.15M

---11.39M

---13.43M

---7.67M

歸属于母公司的淨利潤

50.93%-7.56M

-2.03%-12.98M

59.93%-7.75M

41.31%-9.38M

7.82%-15.40M

24.07%-12.72M

28.66%-19.34M

32.97%-15.99M

51.33%-16.71M

38.10%-16.76M

-1.53%-27.11M

39.67%-23.86M

19.79%-34.34M

47.08%-27.07M

43.09%-26.70M

18.36%-39.54M

-10.10%-42.81M

-31.35%-51.15M

-64.44%-46.91M

-78.25%-48.44M

-121.11%-38.88M

-196.13%-38.94M

-150.54%-28.53M

-102.38%-27.17M

-129.30%-17.59M

---13.15M

---11.39M

---13.43M

---7.67M

歸屬普通股東的淨利潤

50.93%-7.56M

-2.03%-12.98M

59.93%-7.75M

41.31%-9.38M

7.82%-15.40M

24.07%-12.72M

28.66%-19.34M

32.97%-15.99M

51.33%-16.71M

38.10%-16.76M

-1.53%-27.11M

39.67%-23.86M

19.79%-34.34M

47.08%-27.07M

43.09%-26.70M

18.36%-39.54M

-10.10%-42.81M

-31.35%-51.15M

-64.44%-46.91M

-78.25%-48.44M

-121.11%-38.88M

-196.13%-38.94M

-150.54%-28.53M

-102.38%-27.17M

-129.30%-17.59M

---13.15M

---11.39M

---13.43M

---7.67M

基本每股收益

52.47%-2.36

-1884.84%-4.08

-678.52%-2.44

-22735.10%-59.20

-1571.14%-4.96

32.63%-0.21

36.72%-0.31

40.57%-0.26

52.78%-0.30

38.44%-0.31

-0.95%-0.49

40.00%-0.44

20.30%-0.63

47.51%-0.50

43.59%-0.49

19.11%-0.73

-4.13%-0.79

-10.75%-0.94

-38.58%-0.87

-50.14%-0.90

24.09%-0.76

-155.61%-0.85

-116.92%-0.63

-75.68%-0.60

-412.61%-1.00

---0.33

---0.29

---0.34

---0.19

稀釋每股收益

52.47%-2.36

-1884.84%-4.08

-678.52%-2.44

-22735.10%-59.20

-1571.14%-4.96

32.63%-0.21

36.72%-0.31

40.57%-0.26

52.78%-0.30

38.44%-0.31

-0.95%-0.49

40.00%-0.44

20.30%-0.63

47.51%-0.50

43.59%-0.49

19.11%-0.73

-4.13%-0.79

-10.75%-0.94

-38.58%-0.87

-50.14%-0.90

24.09%-0.76

-155.61%-0.85

-116.92%-0.63

-75.68%-0.60

-412.61%-1.00

---0.33

---0.29

---0.34

---0.19

每股派息

--0.00

貨幣單位

--USD

審計意見

----

常見問題

如何在 TradingKey 上查看 Passage Bio Inc 的利潤表？



先看總營收，再依序查看營業成本、毛利、營業費用、營業利益、稅前淨利、淨利和每股盈餘（EPS）。營收反映公司的業務規模，而各項獲利和利潤率則體現公司能否有效地將營收轉化為獲利。

季度利潤表和年度利潤表有什麼區別？



季度利潤表反映公司在一個為期三個月的財務季度內的經營表現，年度損益表則彙總整個財年的業績。季度數據適合用於觀察近期發展勢頭和季節性變化，年度數據則更適合評估長期成長、獲利能力和業務週期。

利潤表頁面中的同比是什麼意思？



同比（即年增率，YoY）是指將某項財務指標與上年同期進行比較，例如將本季度營收與去年同一季度的營收進行對比。與去年同期比較的數據有助於投資者觀察成長趨勢，同時減少正常季節性變化對分析的影響。

分析 PASG 股票時，哪些利潤表指標最重要？



重要的指標包括營收成長、毛利、毛利率、營業利益、營業利益率、淨利、每股盈餘、研發費用、銷售及管理費用以及所得稅費用。投資者通常會綜合分析這些指標，以判斷公司是否正在成長、有效控制成本並提升獲利能力。

Passage Bio Inc 全年的淨利潤是多少？



Passage Bio Inc 2025 財年淨利潤為 -45.52M。

Passage Bio Inc 上一季度的淨利潤是多少？



Passage Bio Inc 最近一個季度的淨利潤為 -7.56M。

Passage Bio Inc 年度營業利潤是多少？



Passage Bio Inc 2025 財年的營業利潤為 -43.15M。

每股收益與利潤表有什麼關係？



每股收益（EPS）通常以淨利潤除以流通在外的股份數量計算，用於衡量公司平均每股創造的利潤。分析 EPS 時，還應結合股本變化、利潤率、現金流和估值指標進行綜合判斷。